green
Positive treatment
2.9 score
Treatment trajectory · 2002 → 2026 · click a year to view as-of
2002
2014
2026
Top citers, strongest first. 4 distinct citers.
How cited ↗
discussed
Cited "see"
Graves v. Mazda Motor Corp.
See Salgado by Salgado v. General Motors Corp., 150 F.3d 735 , 741 n. 6 (7th Cir.1998), cited with approval by our Court of Appeals in Kern River Gas Transmission Co. v. 6.17 Acres of Land, 156 Fed.Appx. 96 at 102 (10th Cir. 2005) (cited as permitted by Tenth Circuit Rule 32. 1.) and Jacobsen v. Deseret Book Co., 287 F.3d 936, 952 (10th Cir.), cert. denied, 537 U.S. 1066 , 123 S.Ct. 623 , 154 L.Ed.2d 555 (2002).
cited
Cited "see"
Voda v. Cordis Corp.
See Jacobsen v. Deseret Book Co., 287 F.3d 936, 953 (10th Cir.), cert. denied, 537 U.S. 1066 , 123 S.Ct. 623 , 154 L.Ed.2d 555 (2002).
cited
Cited "see"
State v. Reddish
See United States v. Davis, 285 F.3d 378, 385 (5th Cir.), cert. denied, 537 U.S. 1066 , 123 S.Ct. 618 , 154 L.Ed.2d 555 (2002).
discussed
Cited "see"
United States v. Carrillo-Lopez
See United States v. Pinedar-Torres, 287 F.3d 860, 865 (9th Cir.), cert. denied, 537 U.S. 1066 , 123 S.Ct. 661 , 154 L.Ed.2d 555 (2002) (distinguishing drug courier testimony from structure testimony).
Retrieving the full opinion text from the archive…
Chambers
v.
United States
v.
United States
02-7224.
Supreme Court of the United States.
Dec 2, 2002.
Published
CHAMBERS
v.
UNITED STATES.
No. 02-7224.
Supreme Court of United States.
December 2, 2002.
1
CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT.
2
C. A. 3d Cir. Certiorari denied. Reported below: 41 Fed. Appx. 525.